ASKA Pharmaceutical

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 26, 2026	Metagen Therapeutics	$7.6M therapeutics	—	Yuto Sasaki, Canon Marketing Japan, MEDIPAL HOLDINGS CORPORATION, Sayuri Okamoto

Total Raised

N/A

Valuation

N/A

Key people at ASKA Pharmaceutical.

Yuto Sasaki

Key people at ASKA Pharmaceutical.

Yuto Sasaki